Objective. The purpose of this study was to compare the usefulness of, and
cost of diagnosing with, different breast biopsy methods for women with cal
cifications highly suggestive of malignancy.
Materials and methods. One hundred thirty-nine women with calcifications hi
ghly suggestive of malignancy underwent diagnostic biopsy. Of these, 89 wom
en had stereotactic biopsy with a 14-gauge automated needle (n = 25), 14-ga
uge vacuum-assisted probe (n = 17), or 11-gauge vacuum-assisted probe (n =
47); and 50 women had diagnostic surgical biopsy. Medical records were revi
ewed. Cost savings for stereotactic biopsy were calculated using Medicare d
ata.
Results. The median number of operations was one for women who had stereota
ctic biopsy versus two for women who had diagnostic surgical biopsy. The li
kelihood of undergoing a single operation was significantly greater for wom
en who had stereotactic rather than surgical biopsy, among all women (61/89
[68.5%] vs. 19/50 [38.0%],p < 0.001) and among women treated for breast ca
ncer (55/77 [71.4%] vs. 6/37 [16.2%], p = 0.0000001). Stereotactic Ii-gauge
vac uum-assisted biopsy, as compared with 14-gauge automated core or 14-ga
uge vacuum-assisted biopsy, was significantly more Likely to spare a surgic
al procedure (36/47 [76.6%] vs. 16/42 [38.1%], p = 0.0005). Stereotactic 11
-gauge vacuum-assisted biopsy resulted in the greatest cost reduction, yiel
ding savings of $315 per case compared with diagnostic surgical biopsy; for
women with solitary lesions, stereotactic 11-gauge biopsy decreased the co
st of diagnosis by 22.2% ($334/$1502).
Conclusion. For women with calcifications highly suggestive of malignancy,
the use of stereotactic rather than surgical biopsy decreases the number of
operations. Stereotactic 11-gauge vacuum-assisted biopsy, as compared with
14-gauge automated core or 14-gauge vacuum-assisted biopsy, is significant
ly more likely to spare a surgical procedure and has the highest cost savin
gs.